(DIAGNOSTIC IMAGING) -- Why invent the wheel when there are perfectly good ones available for the picking? Among the companies looking for an edge through corporate teamwork are: Carestream has signed Technology Partners to a comarketing agreement. Under the agreement, billing software developed by Technology Partners will be integrated into Carestream’s RIS/PACS. The two companies will also promote each other’s wares to their respective installed bases. Mammography Reporting System will build “risk flags” into its breast cancer tracking software to warn patients who are at risk of hereditary breast cancer. These flags will come from the BRACAnalysis breast cancer predisposition test, developed by Myriad (NasdaqGS: MYGN). The test assesses the risk of breast or ovarian cancer based on the detection of BRCA1 and BRCA2 genes. The flags will enable staff at mammography screening centers to identify patients who can benefit from hereditary breast cancer testing. Research cited by the two companies indicates that up to 6% of women undergoing screening mammography—some 2.4 million women—are at high risk of developing hereditary breast cancer.
See full article and related articles at DiagnosticImaging.com
This article was republished with permission from CMPMedica, LLC